2 months MCK Stock Gains as Q2 Earnings & Sales Top Estimates, ’25 EPS View Up Zacks
McKesson’s second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
X